[
  {
    "ts": null,
    "headline": "Cardinal Health (CAH) Ascends While Market Falls: Some Facts to Note",
    "summary": "Cardinal Health (CAH) closed at $133.98 in the latest trading session, marking a +0.93% move from the prior day.",
    "url": "https://finnhub.io/api/news?id=603089a568671c65c121739fa2a6591ecf23f83723f2563ea665e3588d300d7f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743026415,
      "headline": "Cardinal Health (CAH) Ascends While Market Falls: Some Facts to Note",
      "id": 133462418,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "Cardinal Health (CAH) closed at $133.98 in the latest trading session, marking a +0.93% move from the prior day.",
      "url": "https://finnhub.io/api/news?id=603089a568671c65c121739fa2a6591ecf23f83723f2563ea665e3588d300d7f"
    }
  },
  {
    "ts": null,
    "headline": "Merit Medical Stock May Rise as WRAPSODY CIE Shows Strong Results",
    "summary": "MMSI unveils 12-month efficacy data for WRAPSODY CIE, highlighting its advanced technology in vascular access maintenance and potential to improve patient outcomes.",
    "url": "https://finnhub.io/api/news?id=b1fd03ee65dae3a8baa3824fd5146a07d850cf0fa08154e6b83e178ccead4659",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742999760,
      "headline": "Merit Medical Stock May Rise as WRAPSODY CIE Shows Strong Results",
      "id": 133458332,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "MMSI unveils 12-month efficacy data for WRAPSODY CIE, highlighting its advanced technology in vascular access maintenance and potential to improve patient outcomes.",
      "url": "https://finnhub.io/api/news?id=b1fd03ee65dae3a8baa3824fd5146a07d850cf0fa08154e6b83e178ccead4659"
    }
  },
  {
    "ts": null,
    "headline": "Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term",
    "summary": "Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.",
    "url": "https://finnhub.io/api/news?id=5b0973f422b59749b30fe8d190f4486c6c442f8544ce9a7a789029b2f08f9488",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742996408,
      "headline": "Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term",
      "id": 133457391,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.",
      "url": "https://finnhub.io/api/news?id=5b0973f422b59749b30fe8d190f4486c6c442f8544ce9a7a789029b2f08f9488"
    }
  },
  {
    "ts": null,
    "headline": "Cardinal Health, Inc. (CAH) Hits Fresh High: Is There Still Room to Run?",
    "summary": "Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.",
    "url": "https://finnhub.io/api/news?id=6baa03cc62fc437b05d3b79e695a0b71e92da40073719032da7d7b22aabaada8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742994902,
      "headline": "Cardinal Health, Inc. (CAH) Hits Fresh High: Is There Still Room to Run?",
      "id": 133457392,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.",
      "url": "https://finnhub.io/api/news?id=6baa03cc62fc437b05d3b79e695a0b71e92da40073719032da7d7b22aabaada8"
    }
  },
  {
    "ts": null,
    "headline": "DXCM Stock Gains Following New Data on Upcoming G7 CGM Sensor",
    "summary": "DexCom plans to launch its 15-day G7 sensor in the second half of 2025, pending FDA approval. A longer wear time may boost competitive advantage.",
    "url": "https://finnhub.io/api/news?id=f73dabb9cfdd759108768afe3163e709a487767c55d75453d76bb306cf1cf3b3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742987820,
      "headline": "DXCM Stock Gains Following New Data on Upcoming G7 CGM Sensor",
      "id": 133448406,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "DexCom plans to launch its 15-day G7 sensor in the second half of 2025, pending FDA approval. A longer wear time may boost competitive advantage.",
      "url": "https://finnhub.io/api/news?id=f73dabb9cfdd759108768afe3163e709a487767c55d75453d76bb306cf1cf3b3"
    }
  },
  {
    "ts": null,
    "headline": "BDX Stock Declines Following Class I Classification for Alaris Recall",
    "summary": "BD's recall of Alaris infusion pumps following software issues has been classified as the most severe recall by the FDA. A suspension of sales may hurt the top line going forward.",
    "url": "https://finnhub.io/api/news?id=83fccc5361b72d2805b1320ca38558c2624ed0728498d6bd34fdf260c53ca637",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742985180,
      "headline": "BDX Stock Declines Following Class I Classification for Alaris Recall",
      "id": 133448407,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "BD's recall of Alaris infusion pumps following software issues has been classified as the most severe recall by the FDA. A suspension of sales may hurt the top line going forward.",
      "url": "https://finnhub.io/api/news?id=83fccc5361b72d2805b1320ca38558c2624ed0728498d6bd34fdf260c53ca637"
    }
  }
]